Evidence map›Paper›PMID 30701700›Full record

ArticleMicrobiologyOpen2019

Noncontiguous finished genome sequence and description of Raoultibacter massiliensis gen. nov., sp. nov. and Raoultibacter timonensis sp. nov, two new bacterial species isolated from the human gut.

Sory Ibrahima Traore, Melhem Bilen, Mamadou Beye, Awa Diop, Maxime Descartes Mbogning Fonkou, Mamadou Lamine Tall, Caroline Michelle, Muhammad Yasir, Esam Ibraheem Azhar, Fehmida Bibi and 6 more

Expression of concernAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MicrobiologyOpen, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. New microbes and new infections · 2020
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Sory Ibrahima TraoreUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Melhem BilenUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.ORCID 0000-0002-0178-5124
Mamadou BeyeUMR VITROME, IRD, AP-HM, SSA, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Awa DiopUMR VITROME, IRD, AP-HM, SSA, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Maxime Descartes Mbogning FonkouUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Mamadou Lamine TallUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Caroline MichelleUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.
Muhammad YasirSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Esam Ibraheem AzharSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Fehmida BibiSpecial Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Fadi BittarUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.ORCID 0000-0003-4052-344X
Asif Ahmad Jiman-FataniDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Ziad DaoudDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Fréderic CadoretUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.ORCID 0000-0002-9553-8959
Pierre-Edouard FournierUMR VITROME, IRD, AP-HM, SSA, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.ORCID 0000-0001-8463-8885
Sophie EdouardUMR MEPHI, IRD, APHM, IHU Méditerranée-Infection, Aix-Marseille Université, Marseille, France.ORCID 0000-0002-7294-0558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As part of the culturomics project aiming at describing the human microbiota, we report in this study the description of the new bacterial genus Raoultibacter gen. nov. that includes two new species, that is, R. massiliensis sp. nov. and R. timonensis sp. nov. The R. massiliensis type strain Marseille-P2849

Indexed as

Gastrointestinal MicrobiomeActinobacteriaDNA, BacterialFecesGenome, BacterialGenomicsHumansMalePhylogenyRNA, Ribosomal, 16SYoung AdultDNA, BacterialRNA, Ribosomal, 16Sculturomicshuman gut microbiotanew bacterial speciesRaoultibacter massiliensisRaoultibacter timonensistaxonogenomics

Identifiers

PMID30701700
PMCPMC6562231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.